RxDoctor Payments Data

Germaine Cummings

Adult Medicine · Loganville, GANPI 1871544775

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.2% of the total across 199 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Novo Nordisk at 24.5% of the total.

$2,270in general payments, 2019–2025

Across 199 payments — averaging $11.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$555
  • Zyla Life Sciences, Inc.$531
  • AstraZeneca$415
  • Merck$169
  • GSK$116
  • Lilly USA, LLC$80
  • plus $404 from 11 others

What the payments were for

  • Food & beverage$2,22998%
  • Education$412%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,270 in reported general payments places this provider in the 70th percentile of 43 adult medicine providers in Georgia.

See all adult medicine providers in Georgia

Other adult medicine in Loganville

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →